PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17217400-7	2007	Results of in vitro COX selectivity assays showed that etodolac was only slightly selective for COX-2 with a COX-1/COX-2 selectivity ratio effective concentration (EC)50 of 4.32 and for EC80 of 4.77.	Etodolac	55-63	cytochrome c oxidase subunit II	Equus caballus	96-101	
17217400-7	2007	Results of in vitro COX selectivity assays showed that etodolac was only slightly selective for COX-2 with a COX-1/COX-2 selectivity ratio effective concentration (EC)50 of 4.32 and for EC80 of 4.77.	Etodolac	55-63	cytochrome c oxidase subunit II	Equus caballus	115-120	
11202384-7	2000	Conversely, untreated ischaemic tissues or tissues treated with the specific COX-2 inhibitor etodolac (2.7 x 10(-5) mol/l) had significant elevations in PGE2 and PGI2, and significant recovery of transepithelial resistance.	Etodolac	93-101	cytochrome c oxidase subunit II	Equus caballus	77-82	
15563928-4	2005	The objective of the present study was to compare the anti-inflammatory effects of the preferential COX-2 inhibitor etodolac with the non-selective COX inhibitor phenylbutazone in horses with lipopolysaccharide (LPS)-induced synovitis.	Etodolac	116-124	cytochrome c oxidase subunit II	Equus caballus	100-105